Related Experiment Video
Updated: Sep 27, 2026

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
Published on: February 15, 2022
GATA-6 is involved in PPARgamma-mediated activation of differentiated phenotype in human vascular smooth muscle cells
Mitsuru Abe1, Koji Hasegawa, Hiromichi Wada
1Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, 54 Kawara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.
Objective:
Peroxisome proliferator-activated receptor-gamma (PPARgamma) is a member of the nuclear receptor superfamily involved in the growth and differentiation of many cell types. Although the activation of PPARgamma in human vascular smooth muscle cells (VSMCs) inhibits the growth of these cells, the precise mechanism of this effect is unknown. PPARgamma-mediated growth inhibition of VSMCs is associated with the induction of the differentiated phenotype. A zinc finger transcription factor, GATA-6, has been implicated in the maintenance of the differentiated phenotype in VSMCs.
Methods And Results:
The administration of 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2), a naturally occurring PPARgamma ligand, and troglitazone, a thiazolidinedione derivative, induced the expression of smooth muscle myosin heavy chain and smooth muscle alpha-actin, highly specific markers for differentiated VSMCs. Stimulation of proliferative VSMCs with PPARgamma ligands also increased the activity of the transfected wild-type smooth muscle myosin heavy chain promoter but not that of the mutant promoter, in which a GATA-6 binding site was mutated. Compatible with the role of GATA-6, both 15d-PGJ2 and troglitazone upregulated the DNA binding activity of GATA-6 in proliferative VSMCs.
Conclusions:
The activation of PPARgamma-dependent pathways induces the differentiated phenotype in proliferative VSMCs, and this induction is mediated, in part, through a GATA-6-dependent transcriptional mechanism.
Insights
Activation of Peroxisome proliferator-activated receptor-gamma (PPARgamma) in vascular smooth muscle cells (VSMCs) promotes cell differentiation. This process involves the transcription factor GATA-6, highlighting a novel mechanism for controlling VSMC phenotype.
Area of Science:
- Molecular Biology
- Cell Biology
- Cardiovascular Research
Background:
- Peroxisome proliferator-activated receptor-gamma (PPARgamma) is a nuclear receptor influencing cell growth and differentiation.
- PPARgamma activation inhibits human vascular smooth muscle cell (VSMC) growth, but the underlying mechanism remains unclear.
- GATA-6, a zinc finger transcription factor, is crucial for maintaining the differentiated state in VSMCs.
Purpose of the Study:
- To elucidate the mechanism by which PPARgamma activation induces differentiation in VSMCs.
- To investigate the role of GATA-6 in PPARgamma-mediated VSMC differentiation.
Main Methods:
- Treatment of VSMCs with PPARgamma ligands (15d-PGJ2 and troglitazone).
- Assessment of differentiated VSMC markers (smooth muscle myosin heavy chain, alpha-actin).
- Analysis of smooth muscle myosin heavy chain promoter activity using wild-type and mutant constructs.
- Measurement of GATA-6 DNA binding activity.
Main Results:
- PPARgamma ligands induced key markers of VSMC differentiation.
- Ligand treatment enhanced the activity of the smooth muscle myosin heavy chain promoter, dependent on a GATA-6 binding site.
- Both tested PPARgamma ligands increased GATA-6 DNA binding activity in VSMCs.
Conclusions:
- PPARgamma activation drives VSMC differentiation through a GATA-6-dependent transcriptional pathway.
- This study identifies a novel mechanism involving GATA-6 in PPARgamma-mediated VSMC phenotype regulation.
Related Concept Videos
TGF - β Signaling Pathway
Activation and Inactivation of G Proteins
Regulation of Angiogenesis and Blood Supply

